A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (8) · 5060-5073
DOI: 10.1007/s00259-026-07838-x ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 23.03.2026. Verfasst von Hexiao Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lymphoma, Follicular, Deep Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: To develop and validate a prognostic imaging biomarker derived from baseline [¹⁸F]FDG PET/CT using tabular deep learning for prediction of progression of disease within 24 months (POD24) and survival risk stratification in patients with follicular lymphoma (FL). METHODS: This retrospective multicenter study included 309 patients with newly diagnosed FL (grades 1-3a) from five independent medical centers. Tumor volumes segmented from baseline [¹⁸F]FDG PET and CT images were used to extract high-throughput radiomic features. Five conventional machine learning algorithms and four advanced tabular deep learning models were developed and compared. The predictive output of the GAMformer model was defined as the deep learning score (DLS). The DLS was integrated with clinical variables and PET metabolic parameters to construct a multiparametric model in the training cohort. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis, and further validated in validation cohort. RESULTS: During a median follow-up of 44 months, POD24 occurred in 55 patients. The DLS demonstrated strong predictive performance for POD24 (training AUC = 0.857; validation AUC = 0.753). The multiparametric model further improved discrimination, achieving AUCs of 0.882 in the training cohort and 0.797 in the validation cohort, outperforming FLIPI, FLIPI-2, and PRIMA-PI. Calibration showed good agreement, and decision curve analysis indicated higher net clinical benefit. The DLS stratified survival risk (P < 0.05) and remained predictive of survival and POD24 across histologic grades. CONCLUSIONS: The DLS derived from baseline [¹⁸F]FDG PET/CT enables POD24 prediction and accurate survival risk stratification in FL, supporting its potential role in precision management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
- Sichuan University - Pittsburgh Institute, Sichuan University, Chengdu, 610000, China.
- Department of Electrical and Computer Engineering, University of Michigan, Ann Arbor, 48105, USA.
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, No.37, Guoxue Alley, Chengdu, Sichuan, China.
- Department of Hematology, Institute of Hematology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, No.55 Zhenhai Road, Xiamen, China.
- Department of Nuclear Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
ORCID-Profile: Rong Tian
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Innovative Research Group Project of the National Natural Science Foundation of China
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Huang, H., Zhang, T., Jiang, Z., Zhang, Z., Jiang, Q., Teng, Y., Zhou, H., Ding, C., Xu, J., Jiang, M., Xu, B., Jiang, C., Tian, R., & Li, K. (2026). A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging, 53(8), 5060-5073. https://doi.org/10.1007/s00259-026-07838-x
Vancouver
Huang H, Zhang T, Jiang Z, Zhang Z, Jiang Q, Teng Y, et al. A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(8):5060-5073. doi:10.1007/s00259-026-07838-x
BibTeX
@article{Huang2026,
author = {Huang, Hexiao and Zhang, Tingrui and Jiang, Zekun and Zhang, Zitong and Jiang, Qiuhui and Teng, Yue and Zhou, Hang and Ding, Chongyang and Xu, Jingyan and Jiang, Ming and Xu, Bing and Jiang, Chong and Tian, Rong and Li, Kang},
title = {A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {8},
pages = {5060--5073},
doi = {10.1007/s00259-026-07838-x}
}
EUVIMED